JUN 02, 2017 3:13 PM PDT

Bacteria's Contribution to the Fight Against Cancer

WRITTEN BY: Carmen Leitch

Scientists have been interested in using bacteria as engineered factories that are capable of making specialized substances that may also be difficult or expensive to obtain or produce. Researchers have now turned to bacteria to make cytochrome P450 enzymes. These enzymes are critical to the metabolism of foreign compounds in humans and also have important roles in both plant and bacterial cells. The work has been published in Biotechnology and Bioengineering.

These are factories of E. coli bacteria, producing P450, bound to green fluorescent protein. / Credit: DTU

"These powerful compounds can be used as active ingredients in drugs for treating diseases such as cancer and psoriasis," commented lead author Darío Vázquez-Albacete. He performed the work at the Novo Nordisk Foundation Center for Biosustainability, which is managed by the Technical University of Denmark. 

He stressed the diverse impact this work could have, on areas from the reducing harm to the environment and improving the production of cancer drugs. ”The new technique is a significant step forward, as plants produce P450 enzymes in very small amounts, extraction is very complex and sometimes we have to use polluting chemical synthesis processes which involve the use of oil derivatives. Additionally, some plant species such as the yew (Taxus baccata), from which the cancer drug Taxol is obtained, are endangered species,” said Vázquez-Albacete,

"We have developed tools which will allow the proteins from plants that produce these compounds to be recognized by the bacterial molecular machinery. The aim is to use bacteria because they are capable of growing rapidly in controlled fermenters, allowing us to produce large quantities of the enzymes," explained Vázquez-Albacete.

The investigators took advantage of Escherichia coli, a well characterized bacterium, and altered it by adding plant P450 genes. The researchers found that the genome needed some special attention so the bacteria would understand the plant genes.

This is the Spanish researcher Darío Vázquez-Albacete in the laboratory of protein production at the Technical University of Denmark. / Credit: DTU

“In order for the bacteria to properly express the enzymes, the corresponding DNA sequence must frequently be modified to facilitate 'decoding' by the bacteria's system,” said Vázquez-Albacete.

The research team has created an array of various DNA sequences that enables E.coli to synthesize about 50 different plant cytochrome P450 enzymes. Some of these P450 enzymes are involved in drug production Ingenol is used as a treatment for psoriasis, as mentioned some P450 are used to make a cancer drug called Taxol; P450 enzymes that can now be made by bacteria are used in the manufacture of those drugs.

The researcher noted that plants create many compounds that may be of interest to humans as they work to protect themselves from sun exposure, dehydration and other environmental challenges. "Many of these are synthesized by P450s, whose function is still very little understood, so there is enormous potential to discover new compounds.”

 

There are many substances that engineers and scientists have tried to make with bacteria, one example is biodegradable plastic. Learn more from the video.

 

Sources: AAAS/Eurekalert! via FECYT/SINC, Biotechnology and Bioengineering

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 24, 2020
Cell & Molecular Biology
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
AUG 24, 2020
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
Researchers know that the viruses including SARS-CoV-2 have a Spike protein that allows them to bind to receptors on hos ...
AUG 31, 2020
Microbiology
Finding a Weakness in an Emerging Drug-Resistant Pathogen
AUG 31, 2020
Finding a Weakness in an Emerging Drug-Resistant Pathogen
Candida auris is a fungal pathogen that was initially reported in 2009. Its origins are unclear, but it has been found i ...
OCT 05, 2020
Plants & Animals
Bacteria Caused the Deaths of Hundreds of Elephants
OCT 05, 2020
Bacteria Caused the Deaths of Hundreds of Elephants
African elephants are a threatened species that are increasing in some areas but at risk in many others. There are proba ...
OCT 29, 2020
Microbiology
Metabolomics and the Microbiome
OCT 29, 2020
Metabolomics and the Microbiome
The average person contains large variations in bacteria from the mouth, the skin, sweat, and in the stomach and intesti ...
NOV 06, 2020
Microbiology
Daily Aspirin Users Less Likely to Die From COVID-19
NOV 06, 2020
Daily Aspirin Users Less Likely to Die From COVID-19
Recent work has backed up research from earlier this year that suggested that aspirin might help prevent the worst cases ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
Loading Comments...